Quantum biophotonics for human longevity biotech development
Subscribe: Apple Podcasts | Google Podcasts | Spotify | RSS | More
For advancing disease-cure drug design and manufacturing medical biotech, human longevity biotech, medical human body manufacturing and replacement biotech, human genetic engineering biotech, and neurotech, I need to advance microscopic human body 3D scanner that can detect and record every single cell in the human body.
In order to advance microscopic human body 3D scanner, I need to advance quantum biophotonics.
The key question I need to answer in quantum biophotonics is this: “What’s the biophysical mathematical relationship between light wave frequency, light intensity, light photon momentum and energy, biomatter light penetration, and light reflection in biomatter such as DNA, cell, and tissue?” I will answer this question, both theoretically and experimentally, and publish my answer, when the right time comes.
A quick advertisement before I continue on this topic. You can invest in my startup company with as little as US$100, for supporting advancing AI, robotics, biotech, and nuclear-fusion powered outer space tech. Visit Robocentric.com/Investors to invest in my startup.
I’ve a multidecadal commitment to advancing AI, robotics, biotech, and nuclear-fusion powered outer space tech. To learn more about my cause, check out my books, which are available at Robocentric.com/Checkout, Amazon, Apple Books, Spotify, and other online audiobook retailers. Now, back to the main content.
Advances in quantum biophotonics will have numerous beneficial applications in biotech, especially in advancing medical biotech and human longevity biotech.
One key application of quantum biophotonics that I envision is measuring telomere length very cheaply, for developing cancer cure and advancing human longevity biotech.
Another application of quantum biophotonics that I envision is a cheap light-based sensor or scanner that can determine and record 3D protein structures, such as telomerase. Something cheaper than x-ray crystallography machine or x-ray diffratometer, which costs about US$29,999 to US$68,000.
X-Ray Diffraction (XRD) allows ascertaining the molecular structure of a crystalline material by diffracting x-rays through the sample. An XRD analyzer obtains interference patterns reflecting lattice structures by varying the angle of incidence of the X-Ray beam.
As of right now, scanning and recording biomatter at microscopic and nanoscopic levels is too expensive, too slow, too cumbersome, and too limited.
To advance biotech, there has to be a technology that can scan and record cellular and subcellular biomatter at microscopic and nanoscopic levels, very cheaply, very quickly, very easily, in massive quantities such as trillions of cells, chromosomes, and proteins.
Quantum biophotonics needs to be advanced for advancing biotech, so I’ll do my part in advancing quantum biophotonics as much and quickly as God permits me to.
You can invest in my startup company with as little as US$100, for supporting advancing AI, robotics, biotech, and nuclear-fusion powered outer space tech. Visit Robocentric.com/Investors to invest in my startup.
My books on advancing AI, robotics, biotech, and nuclear-fusion powered outer space tech are available at Robocentric.com/Checkout, Amazon, Apple Books, Spotify, Google Play Store, and other online audiobook retailers.
I am Allen Young; I’m an Asian-American man who focuses on advancing AI, robotics, human longevity biotech, and nuclear-fusion powered outer space tech.